| Gerald Stewart Buntin, MD | |
|
1917 Glatt St, Eureka, CA 95503-5608 | |
| (864) 387-9741 | |
| Not Available |
| Full Name | Gerald Stewart Buntin |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 16 Years |
| Location | 1917 Glatt St, Eureka, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043478456 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 30806 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Hospital | Eureka, CA | Hospital |
| Mad River Community Hospital | Arcata, CA | Hospital |
| Redwood Memorial Hospital | Fortuna, CA | Hospital |
| Sutter Coast Hospital | Crescent city, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Medical Foundation | 8921993205 | 1293 |
News Archive
Because of genetic testing, Orion Maynard's parents knew the cause of his epilepsy weeks after he was born.
Researchers at Binghamton University, State University of New York, have identified three key regulators required for the formation and development of biofilms. The discovery could lead to new ways of treating chronic infections.
An overactive molecular signal pathway in the brain region of the amygdala can lead to obsessive-compulsive disorder (OCD). A research team from Würzburg has established this connection.
A team of researchers, affiliated with UNIST has recently introduced a novel targeted drug delivery system that can improve the pharmacological and therapeutic properties of conventional cancer treatments.
LEAD Therapeutics, a privately held drug discovery company, announced the discovery of a novel antibiotic with potent activity against many of the most common antibiotic resistant bacteria.
› Verified 8 days ago
| Entity Name | Providence Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285890624 PECOS PAC ID: 8921993205 Enrollment ID: O20040216001346 |
News Archive
Because of genetic testing, Orion Maynard's parents knew the cause of his epilepsy weeks after he was born.
Researchers at Binghamton University, State University of New York, have identified three key regulators required for the formation and development of biofilms. The discovery could lead to new ways of treating chronic infections.
An overactive molecular signal pathway in the brain region of the amygdala can lead to obsessive-compulsive disorder (OCD). A research team from Würzburg has established this connection.
A team of researchers, affiliated with UNIST has recently introduced a novel targeted drug delivery system that can improve the pharmacological and therapeutic properties of conventional cancer treatments.
LEAD Therapeutics, a privately held drug discovery company, announced the discovery of a novel antibiotic with potent activity against many of the most common antibiotic resistant bacteria.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gerald Stewart Buntin, MD 1917 Glatt St, Eureka, CA 95503-5608 Ph: (864) 387-9741 | Gerald Stewart Buntin, MD 1917 Glatt St, Eureka, CA 95503-5608 Ph: (864) 387-9741 |
News Archive
Because of genetic testing, Orion Maynard's parents knew the cause of his epilepsy weeks after he was born.
Researchers at Binghamton University, State University of New York, have identified three key regulators required for the formation and development of biofilms. The discovery could lead to new ways of treating chronic infections.
An overactive molecular signal pathway in the brain region of the amygdala can lead to obsessive-compulsive disorder (OCD). A research team from Würzburg has established this connection.
A team of researchers, affiliated with UNIST has recently introduced a novel targeted drug delivery system that can improve the pharmacological and therapeutic properties of conventional cancer treatments.
LEAD Therapeutics, a privately held drug discovery company, announced the discovery of a novel antibiotic with potent activity against many of the most common antibiotic resistant bacteria.
› Verified 8 days ago
Wahidullah Wahidullah, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: St Joseph Hospital - Eureka, 2700 Dolbeer St, Eureka, CA 95501 Phone: 707-445-8121 | |
Samuel D Rose, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 2700 Dolbeer Street, Eureka, CA 95501 Phone: 503-215-6600 |